Guillermo, Misty Rose 2.

HRN: 19-74-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2022
CEFUROXIME 1.5GM (VIAL)
12/02/2022
12/02/2022
IV
1.5
On Call To OR
CS With BTL
Waiting Final Action 
12/02/2022
CEFUROXIME 750MG (VIAL)
12/02/2022
12/03/2022
IV
750 Mg
Q8
Post CS X 3
12/03/2022
CEFUROXIME 500MG (TAB)
12/03/2022
12/09/2022
ORAL
500
BID
Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: